Karen A. Dawes - 13 Jul 2021 Form 4/A - Amendment Insider Report for REPLIGEN CORP (RGEN)

Role
Director
Signature
/s/ Kimberly Brown (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
13 Jul 2021
Net transactions value
-$186,749
Form type
4/A - Amendment
Filing time
22 Jul 2021, 18:53:49 UTC
Date Of Original Report
15 Jul 2021
Previous filing
17 May 2021
Next filing
22 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $120,646 +2,929 +2.5% $41.19 118,982 13 Jul 2021 Direct
transaction RGEN Common Stock Sale $88,760 -441 -0.37% $201.27 118,541 13 Jul 2021 Direct F1, F2
transaction RGEN Common Stock Sale $127,443 -630 -0.53% $202.29 117,911 13 Jul 2021 Direct F1, F3
transaction RGEN Common Stock Sale $90,172 -444 -0.38% $203.09 117,467 13 Jul 2021 Direct F1, F4
transaction RGEN Common Stock Sale $1,020 -5 -0% $204.02 117,462 13 Jul 2021 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +2,929 $0.000000* 0 13 Jul 2021 Common Stock 2,929 $41.19 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.
F2 $201.27 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.77 to $201.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 $202.29 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.77 to $202.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 $203.09 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.86 to $203.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 $204.02 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.01 to $204.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F6 This option is fully vested and exercisable.

Remarks:

This Form 4/A amends a Form 4 filed on 7/15/2021 to correct the presentation of the stock sold to reflect the multiple transactions to sell the total 1,520 shares.